By Daniella Parra Promontory Therapeutics said its Phase 2 meeting with the FDA cleared the way to launch a Phase 3 registrational trial of PT-112 monotherapy for metastatic castration-resistant prostate cancer. The company is a small, NYC-based biotech that, to...

By Karen Roman ReAlta Life Sciences said it presented new clinical data from its Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AE-COPD) program at the American Thoracic Society 2025 International Conference, taking place on May 18-21, in San Francisco. The...

By Karen Roman Grove Collaborative Holdings, Inc. (NYSE: GROV) said total revenue was $43.5 million, 18.7% less compared to $53.5 million the year prior, partly due to its eCommerce platform migration. Adjusted EBITDA was $(1.6) million compared to $1.9 million...

By Daniella Parra Waldencast plc (Nasdaq: WALD) said net revenue decreased 4.1% year-over-year to $65.4 million and adjusted gross profit totaled $50.0 million, or 76.4% of net revenue, an expansion of 10 basis points compared to the prior year. Adjusted...

By Karen Roman a.k.a. Brands Holding Corp. (NYSE: AKA) said first quarter net sales grew 10.1% to $128.7 million, compared to $116.8 million the year prior, with U.S. net sales increasing 14.2%. Adjusted EBITDA was $2.7 million, or 2.1% of...

Download the Complete Report Here By Rayk Riechmann As a leading natural resource firm based in heart of the US with an established domestic customer base, Alliance Resource Partners, L.P. (Nasdaq: ARLP) may offer the hedge against global trade uncertainty...

Contact: Executives-Edge.com Rayk@capmarketsmedia.com

By Daniella Parra Jeito Capital said it is leading a €132 million oversubscribed Series B funding round in Azafaros, a clinical-stage biotech company developing treatments for rare lysosomal storage disorders.  Azafaros, founded in 2018 and rooted in Dutch academic research,...

By Daniella Parra On Holding AG (NYSE: ONON) said net sales increased 43% to CHF 726.6 million as it  increased its direct-to-consumer share, accounting for 38.1% of total net sales. The Swiss-designed running shoe and apparel maker reported a gross...

Vista secures significant new capital while a court ruling clears founder Thomas Flohr of allegations, positioning the company for continued global expansion. By Exec Edge Editorial Staff A major court ruling dismissed the case against VistaJet founder Thomas Flohr, clearing...